Management of Adenocarcinoma in a Columnar-Lined Esophagus

Harle, Ingrid; Finley, Richard J.; Belsheim, M.R.; Bondy, Donald C.; Booth, Martin; Lloyd, D. A.; McDonald, John W.D.; Sullivan, Stephen N.; Valberg, L. S.; Watson, W.C.; Frei, John V.; Slinger, Robert P.; Troster, Michael; Meads, G E; Duff, John

doi:10.1016/s0003-4975(10)60062-8

Cited by 61 publications

(11 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Whether all patients with Barrett's epithelium or only a subgroup with risk factors for the development of adenocarcinoma should be screened remains controversial. Harle et al [7] and Ransom et al [8] suggested a positive relationship between the extension of Barrett's epithelium and the risk of developing adenocarcinoma in the esophagus. The Rotterdam Esophageal Tumor Study Group demonstrated that doubling the length of Barrett's epithelium increased the risk of adenocarcinoma by 1.7 times [9].…”

Section: Introductionmentioning

confidence: 99%

Risk Factors for the Progression of Endoscopic Barrett’s Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria

et al. 2008

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Risk Factors for the Progression of Endoscopic Barrett’s Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria

et al. 2008

View full text Add to dashboard Cite

show abstract

“…Entre el 68 al 100% la displasia se encuentra asociada a adenocarcinoma (21,62,63,64). En los pacientes con EB que no presentan adenocarcinoma, la incidencia de displasia es sólo del 5% al 10% (60,65,66).…”

Section: Rev Med Hered 9(1) 1998 45unclassified

Esófago de Barret en Pediatría: Revisión de la literatura a propósito de un caso.

Tori¹,

Stella²,

Rey³

2013

Rev Med Hered

View full text Add to dashboard Cite

SUMMARYThis patient presented at one year of age with a dry and persistent cough prodominantly nocturnal, pneumonia on two occasions, and signs and symptoms compatible with bronchial asthma. Due to the high incidence of gastroesophageal reflux in patients with esophageal atresia , an entity that could be responsible for his symptoms, diagnostic procedures were done to confirm this diagnosis, and treatment was begun with cisapride during one month, but without improvement. It was then that a esophagogastroscopy was performed and Barrett's esophagus was diagnosed. The patient was medicated with cisapride and omeprazole, and two months later a Thal Fundoplication was done. The patient has continued on cisapride and omeprazole with great improvement, being asymptomatic for a period of nine months, and having had only on one occasion a respiratory crisis due to bronchospasm. A repeat esophagogastroscopy has been planned one year after his operation. ( Rev Med Hered 1998; 9: ).KEY WORDS: Barrett's esophagus, gastroesophageal reflux, adenocarcinoma, esophageal neoplasm. INTRODUCCIONSe presenta un niño quien presentaba desde el año de edad, tos seca exigente a predominio vespertino, presentando neumonía basal derecha y parahiliar derecha en dos ocasiones, y signos compatibles con asma bronquial. Se inició tratamiento con cisaprida ante la posibilidad de reflujo gastroesofágico durante un mes sin presentar mejoría. Se le realizó una esofagogastroscopía donde se diagnostica esófago de Barrett, recibiendo omeprazol y cisaprida, para luego procederse a una Fundoplicatura de Thal.Debido a la presentación infrecuente de esta entidad en niños se presenta este caso y se hace una revisión de la enfermedad. Caso ClínicoJGCH, varón, nacido a las 43 semanas de gestación por cesárea, por falta de dilatación uterina, con buen Apgar, pesando 3050 gms y con 47 cms de talla. Madre de 25 años, sana, primer embarazo; padre de 25 años, sano salvo paresia congénita de los músculos externos del ojo izquierdo. _________________________________________________________________________________

show abstract

“…We realized a review of the literature since 1970 to answer the question of frequency and reliability of regression. Twenty-five series including 830 patients and 6 case reports were found, totaling 836 patients suitable for analysis [16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46]. The design of the series was prospective and randomized (n=1), prospective (n=6), and retrospective (n=18).…”

Section: Regression Of Barrett's Esophagus After Antireflux Surgerymentioning

confidence: 99%

“…This is a crucial point, because unsuccessful ARS leaves the patient exposed to reflux, and no potential benefit compared with patients without any treatment can be expected. In 14 series totaling 427 patients, ARS in patients with BE was judged successful by clinical means or esophageal function testing [17,18,19,20,21,22,23,24,25,26,27,28,29,30]. The design of the series was prospective (n=2) and retrospective (n=12).…”

Section: Regression Of Barrett's Esophagus After Antireflux Surgerymentioning

confidence: 99%

See 1 more Smart Citation

Impact of antireflux surgery on Barrett's esophagus

Gutschow

Schröder

Prenzel

et al. 2002

Langenbeck's Archives of Surgery

View full text Add to dashboard Cite

show abstract

Management of Adenocarcinoma in a Columnar-Lined Esophagus

Cited by 61 publications

References 19 publications

Risk Factors for the Progression of Endoscopic Barrett’s Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria

Risk Factors for the Progression of Endoscopic Barrett’s Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria

Esófago de Barret en Pediatría: Revisión de la literatura a propósito de un caso.

Impact of antireflux surgery on Barrett's esophagus

Contact Info

Product

Resources

About